May 10 (Reuters) - Biolife Solutions Inc BLFS.O :
* BIOLIFE SOLUTIONS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* REAFFIRMING 2023 REVENUE GUIDANCE
* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES AS OF
MARCH
31, 2023, WERE $56.9 MILLION.
* QTRLY LOSS PER SHARE $0.32
* Q1 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA
* MANAGEMENT EXPECTS GROSS MARGIN AND ADJUSTED EBITDA
EXPANSION IN
2023
Source text for Eikon: ID:nPn47ckXxa
Further company coverage: BLFS.O
((Reuters.Briefs@thomsonreuters.com;))